Original Publication Date: 1 May, 2014
Publication / Source: Future Oncology
Authors: Enrica Capelletto, Silvia Novello, Giorgio V Scagliotti
Lung cancer is the leading cause of cancer-related mortality worldwide in both sexes, expected to account, in the near future, for more than 30% of all cancer-related deaths. Recently, improvements in the systemic therapy of non-small-cell lung cancer according to histology and tumor molecular characteristics led to a progressive prolongation of survival, more clinically meaningful in selected groups of patients with tumors harboring specific genomic alterations.